Achieving Better Outcomes and Patient Care
Our understanding of the molecular and neurobiologic underpinnings of addiction has progressed very quickly over the past several decades. Both clinical and basic science research have contributed to these efforts and as a result, behavioral and pharmacological treatments continue to be validated and improved, leading to better outcomes and patient care. We not only use and draw from evidence-based practices, but incorporate research into our patient care efforts, such that we can contribute to the development of more effective treatments.
We are affiliated with Yale School of Medicine's Department of Psychiatry and the Yale Psychotherapy Development Center. As part of the Yale Psychotherapy Development Center, the majority of our faculty and staff hold research appointments in the Department of Psychiatry. Through interdisciplinary collaborative efforts between psychiatrists, psychologists, geneticists, neuroscientists and treatment researchers, we work closely together to develop and evaluate emerging treatments in a team-based approach.
Advancing the Knowledge and Treatment of Addition
We are constantly developing and expanding our research efforts to incorporate neuroimaging and genetic techniques to both advance the knowledge of addictions and other psychiatric disorders, and to improve our treatment of these disorders.